| Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma ... - PR-CANADA.net (press release) |
|
|
PR-CANADA.net (press release)Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable progression-free survival (PFS) ... read more |